115 related articles for article (PubMed ID: 7955606)
41. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.
Birkenhäger-Gillesse EG; Derksen J; Lagaay AM
Ann N Y Acad Sci; 1994 May; 719():543-52. PubMed ID: 8010622
[TBL] [Abstract][Full Text] [Related]
42. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.
Escribá A; Morales E; Albizúa E; Herrero JC; Ortuño T; Carreño A; Dominguez-Gil B; Praga M
Am J Kidney Dis; 2000 Jan; 35(1):137-40. PubMed ID: 10620555
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls.
Demir H; Tanriverdi F; Ozoğul N; Caliş M; Kirnap M; Durak AC; Keleştimur F
Scand J Rheumatol; 2006; 35(3):217-23. PubMed ID: 16766369
[TBL] [Abstract][Full Text] [Related]
44. Serum dehydroepiandrosterone sulfate levels as an individual marker.
Thomas G; Frenoy N; Legrain S; Sebag-Lanoe R; Baulieu EE; Debuire B
J Clin Endocrinol Metab; 1994 Nov; 79(5):1273-6. PubMed ID: 7962319
[TBL] [Abstract][Full Text] [Related]
45. [Glucocorticoid treatment improves glucose tolerance in patients with temporal arteritis or polymyalgia rheumatica].
Sáez Barcelona JA; Carmona Martín M; Navarro López V; Blanch Sancho JJ; Puras Tellaeche A
Rev Clin Esp; 1999 May; 199(5):270-4. PubMed ID: 10396146
[TBL] [Abstract][Full Text] [Related]
46. Lipoprotein(a) and anticardiolipin antibodies as risk factors for thrombotic events in polymyalgia rheumatica and giant cell arteritis.
Seriolo B; Accardo S; Cutolo M
J Rheumatol; 1996 Aug; 23(8):1478-80. PubMed ID: 8856634
[No Abstract] [Full Text] [Related]
47. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
Miklós S
Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
[TBL] [Abstract][Full Text] [Related]
48. Polymyalgia rheumatica and giant cell arteritis.
Ettlinger RE; Hunder GG; Ward LE
Annu Rev Med; 1978; 29():15-22. PubMed ID: 348031
[No Abstract] [Full Text] [Related]
49. [Polymyalgia rheumatica. Clinical histological study of 46 cases].
Gerber N; Vernon-Roberts B
Z Rheumatol; 1977; 36(9-10):275-84. PubMed ID: 930423
[TBL] [Abstract][Full Text] [Related]
50. Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.
Overman CL; Hartkamp A; Bossema ER; Bijl M; Godaert GL; Bijlsma JW; Derksen RH; Geenen R
Lupus; 2012 Dec; 21(14):1515-21. PubMed ID: 22936125
[TBL] [Abstract][Full Text] [Related]
51. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Repeated measurements of erythrocyte sedimentation rate are not efficient use of time or resources.
Roome P
BMJ; 1997 Aug; 315(7107):550. PubMed ID: 9329329
[No Abstract] [Full Text] [Related]
52. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis.
Lundberg I; Hedfors E
J Rheumatol; 1990 Oct; 17(10):1340-5. PubMed ID: 2254893
[TBL] [Abstract][Full Text] [Related]
53. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[TBL] [Abstract][Full Text] [Related]
54. Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.
Puccetti L; Marotta G; Remorini E; Lucchetti A; Zuccotti M; Petrini G; Baicchi U; Ciompi ML
Rheumatol Int; 1987; 7(6):249-54. PubMed ID: 3125593
[TBL] [Abstract][Full Text] [Related]
55. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
56. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
57. Association of ferritin antibodies with Takayasu arteritis.
Große K; Witte T; Moosig F; Hoyer BF; Lansche C; Schmidt RE; Baerlecken NT
Clin Rheumatol; 2014; 33(10):1523-6. PubMed ID: 25178778
[TBL] [Abstract][Full Text] [Related]
58. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94.
Gran JT; Myklebust G
J Rheumatol; 1997 Sep; 24(9):1739-43. PubMed ID: 9292797
[TBL] [Abstract][Full Text] [Related]
59. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Panayi GS
Br J Rheumatol; 1990 Dec; 29(6):456-8. PubMed ID: 2124160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
